These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1305 related articles for article (PubMed ID: 17605727)
21. Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients. Hamza NS; Ghannoum MA; Lazarus HM Bone Marrow Transplant; 2004 Sep; 34(5):377-89. PubMed ID: 15247928 [TBL] [Abstract][Full Text] [Related]
22. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448 [TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A; Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759 [TBL] [Abstract][Full Text] [Related]
25. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents. Strasfeld L; Weinstock DM Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622 [TBL] [Abstract][Full Text] [Related]
26. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362 [TBL] [Abstract][Full Text] [Related]
27. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692 [TBL] [Abstract][Full Text] [Related]
28. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases]. Karthaus M; Böhme A Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423 [TBL] [Abstract][Full Text] [Related]
29. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Hovi L; Saxen H; Saarinen-Pihkala UM; Vettenranta K; Meri T; Richardson M Pediatr Blood Cancer; 2007 Jan; 48(1):28-34. PubMed ID: 16395687 [TBL] [Abstract][Full Text] [Related]
30. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation. Camps IR Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA). Ito JI; Chandrasekar PH; Hooshmand-Rad R Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663 [TBL] [Abstract][Full Text] [Related]
32. Invasive aspergillosis: diagnosis, prophylaxis and treatment. Del Bono V; Mikulska M; Viscoli C Curr Opin Hematol; 2008 Nov; 15(6):586-93. PubMed ID: 18832929 [TBL] [Abstract][Full Text] [Related]
33. Successful treatment of patients with respiratory failure due to fungal infection after allogeneic hematopoietic stem cell transplantation. Koldehoff M; Elmaagacli AH; Steckel NK; Trenschel R; Hlinka M; Ditschkowski M; Beelen DW Transpl Infect Dis; 2005; 7(3-4):137-45. PubMed ID: 16390403 [TBL] [Abstract][Full Text] [Related]
34. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840 [TBL] [Abstract][Full Text] [Related]
39. Time trends in fungal infections as a cause of death in hematopoietic stem cell transplant recipients: an autopsy study. Alsharif M; Cameron SE; Young JA; Savik K; Henriksen JC; Gulbahce HE; Pambuccian SE Am J Clin Pathol; 2009 Nov; 132(5):746-55. PubMed ID: 19846817 [TBL] [Abstract][Full Text] [Related]
40. New developments in the diagnosis and management of invasive fungal infections. De Marie S Haematologica; 2000 Jan; 85(1):88-93. PubMed ID: 10629598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]